《港股》恆指半日升470點 騰訊績前漲逾3% 阿里升逾4%
美上月通脹符預期,市場憧憬美聯儲下月減息,美股標普500指數及納指破頂,道指升1.1%。港股早市上升,恆指高開206點後升幅擴大,半日升470點或1.9%,報25,439點;國指升165點或1.9%,報9,082點;恆生科技指數升127點或2.3%,報5,506點。大市半日成交總額1,437.85億元。
騰訊音樂(01698.HK)次季非國際財務報告準則純利升37%勝市場預期,股價升15.2%。同業網易雲音樂(09899.HK)炒高8.3%。將於日內公布業績的騰訊(00700.HK)升3.1%報577元。
其他科技股方面,阿里(09988.HK)升4.4%,京東(09618.HK)、美團(03690.HK)、百度(09888.HK)及快手(01024.HK)升2.9%至3.6%,嗶哩嗶哩(09626.HK)升5.5%,網易(09999.HK)及中芯(00981.HK)升2.5%及1.1%。閱文(00772.HK)中期純利增68.5%獲大行唱好,股價升18.7%。此外,微盟(02013.HK)升6.9%,平安好醫生(01833.HK)升3.8%。手機部件股丘鈦(01478.HK)升8.3%,瑞聲(02018.HK)、藍思(06613.HK)及舜宇(02382.HK)升4.6%至5.3%。
車股方面,小米(01810.HK)及比亞迪(01211.HK)升2.2%及2.8%,蔚來(09866.HK)及小鵬(09868.HK)跌逾3%。汽車代理中升(00881.HK)升4.5%。消費股方面,萬洲(00288.HK)上半年生物公允價值調整前純利升4.5%,中期息倍升至20仙,股價升5.6%。毛戈平(01318.HK)收入增逾三成,預告半年多賺35%至37%,股價高開3.4%,半日倒跌1.6%。大麥娛樂(01060.HK)升7.1%。濠賭股銀娛(00027.HK)回吐2.9%。
藥股造高,信達生物(01801.HK)及康龍化成(03759.HK)升7.3%及6.4%,金斯瑞(01548.HK)、威高(01066.HK)、翰森(03692.HK)、百濟神州(06160.HK)及石藥(01093.HK)升4.4%至5.5%,藥明康德(02359.HK)升4%。
金融股方面,匯控(00005.HK)升1.4%報101.6元,港交所(00388.HK)及友邦(01299.HK)升2%及2.4%。上證指數升至逾4年高位,券商股中信建投(06066.HK)及華泰證券(06886.HK)各升逾4%。資源股急漲,五礦資源(01208.HK)及江銅(00358.HK)升9.5%及5.8%,洛鉬(03993.HK)升3.6%。電訊股聯通(00762.HK)中期純利符預期,股價升3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.